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A B S T R A C T
The aim of the study was to determine drug utilization according to Croatian counties, and to identify the causes of
the possible between-county utilization variation. Zagreb Institute of Public Health in collaboration with the Croatian
Drug Agency collected and analyzed data on outpatient utilization of the six main Anatomic-Therapeutic-Chemical (ATC)
drug groups. Data on the number and size of packages, and on wholesale price were obtained from all pharmacies in
Croatia. Based on these data, the number of defined daily doses (DDD) and DDD per 1000 inhabitants per day (DDD/
1000/day) in 2004 were calculated for all drugs. County differences in the drugs utilization were calculated by use of rel-
ative standard deviation. This method revealed the outpatient drug utilization to vary among particular Croatian coun-
ties. Study results indicated the need of national guidelines for appropriate drug use to develop, along with education of
the physicians and general population on their implementation.
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Introduction
The utilization and appropriate use of drugs are the
subject of numerous economic discussions and topic of
professional and scientific papers worldwide. In 2006,
the utilization of drugs in the world has increased by
6%–7% and is anticipated to rise by another 5%–6% in
20071. The growing drug cost is influenced by an ever
greater proportion of new drugs, which as a rule are
more expensive2. In contrast to the world patterns, in
Croatia the mean drug cost in 2005 was lower 8% as com-
pared with 2004. However, in spite of the considerable re-
duction of drug prices in Croatia, which has been effec-
tive as of August 2004, financial indicators released by
the Croatian Institute of Health Insurance (CIHI) show
the 2005 drug utilization to exceed the 2004 one by 3%,
amounting to 3.738.927.612 HRK3. Besides drug prices,
the rise in drug costs is influenced by the extended life
expectancy, entailing an ever greater share of chronic dis-
eases in the cost of pharmacotherapy and treatment in
general. The cost of treatment of chronic diseases is con-
sidered to account for 78% of overall health care costs4,5.
In the conditions of increasing demands, appropriate use
of drugs should be encouraged as the best protection
from uncontrolled drug expenditure increase. Rational
pharmacotherapy implies optimal drug dosage to achieve
the maximum possible cure rate6,7. Standardized meth-
ods of drug utilization monitoring by use of the Ana-
tomic-Therapeutic-Chemical (ATC) classification and de-
fined daily dose (DDD), i.e. ATC/DDD methodology rele-
ased by the World Health Organization (WHO) should be
established as a basis of an economic approach to drug
utilization8. Standard methodology is a precondition for
the intervention measures to employ and properly eva-
luate9,10. High quality prescribing policy and practice,
based on the physician’s knowledge and experience, exis-
tence of quality prescribing guidelines, and implementa-
tion of the guidelines in daily practice, at primary health
care level in particular, as it accounts for 80%–90% of
drug utilization in Croatia as well as in the world, make
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another important factor in rational drug prescrib-
ing7,11–13. Determination of drug utilization by use of
ATC/DDD methodology revealed great differences be-
tween different countries and regions14. This variation
results from different morbidity indicators, differences
in prescribing guidelines, and differences in the physi-
cians’ compliance with the guidelines14.
The aim of the present study was to determine drug
utilization according to counties in the Republic of Cro-
atia, and to identify the causes of the potential be-
tween-county differences.
Methods
Based on the By-Law on the Type of Data and Mode of
Reporting on Medicine Marketing15, Zagreb Institute of
Public Health in collaboration with National Drug Agen-
cy collected and analyzed data on outpatient utilization
of drugs from the six main ATC groups, i.e. A – gastroin-
testinal and metabolic agents; C – cardiovascular drugs;
J – drugs for treatment of systemic infections; M – mus-
culoskeletal agents; N – central nervous system agents;
and R – respiratory system agents.
Data on the number and size of packages, and on
wholesale prices were obtained from all pharmacies in
Croatia. Information on the total number of pharmacies
and their units was obtained from Personnel Registry
kept at Croatian Institute of Public Health. Drugs were
grouped according to the ATC classification system. Ba-
sed on these data, the number of defined daily doses
(DDD) and DDD per 1000 inhabitants per day (DDD/
1000/day) in 2004 were calculated for all drugs according
to the WHO ATC/DDD index16. On calculating the num-
ber of DDD/1000/day for the Republic of Croatia, particu-
lar counties and the City of Zagreb, data from the 2001
census, kept at the National Bureau of Statistics, were
used17. Equivalent dose (ED) was used in case of drug
combinations where DDD was not available18. Between-
-county differences in drug utilization for the six ATC
groups included in the study were calculated by use of
relative standard deviation (RSD) defined as:
standard deviation of the main anatomical group of drugs
at primary level of ATC system, expressed as percentage
(%) of total drug utilization of
RSD= all six groups in a particular county ´ 100
mean utilization of the respective group of drugs in Croa-
tia, expressed as percentage (%) of overall utilization in
Croatia
A higher RSD value indicates greater between–county
differences in the utilization of particular drug groups.
Similar measures have also been employed in other in-
ternational studies assessing variation in drug utiliza-
tion between particular countries13,19.
Morbidity indicators of diseases and states, estab-
lished at primary health care in Croatia as a whole, in
Croatian counties and in the City of Zagreb in 2004, were
provided by the Croatian Institute of Public Health to as-
sess the causes of the possible between-county differ-
ences in drug utilization. Based on these data, morbidity
rate per 1000 inhabitants at primary health care level
was calculated for the leading groups of states and dis-
eases. Diseases were grouped according to the Interna-
tional Classification of Diseases 10th Revision (ICD X)20.
Results
Outpatient utilization of the six main groups of pre-
scription drugs at primary level of the ATC system in
Croatia in 2004 is presented in Table 1.
Cardiovascular agents accounted for almost a half of
the outpatient prescription drug utilization. In group C,
a major proportion of utilization (30%) referred to agents
acting on the renin-angiotensin system (C09), predomi-
nated by pure ACE inhibitors and followed by agents act-
ing on the central nervous system. Psycholeptics (N05)
accounted for more than a half of the latter group utiliza-
tion (66%), with 82% referring to benzodiazepines. These
were followed by gastrointestinal system agents, where
antidiabetics predominated with 45% of utilization. The
musculoskeletal system agents ranked fourth, with 86%
of their utilization referring to anti-inflammatory agents
and antitheumatics (M01), followed by respiratory sys-
tem agents with the highest proportion (47%) of drugs
for obstructive airway diseases (R03). The agents used in
the treatment of systemic infections showed lowest utili-
zation, with antibiotics (J01) accounting for 97% of their
utilization. Outpatient utilization of the six main ATC
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TABLE 1
OUTPATIENT UTILIZATION OF SIX MAIN ATC PRESCRIPTION DRUG GROUPS AT PRIMARY LEVEL OF ATC SYSTEM IN CROATIA IN
2004, EXPRESSED SA DDD/1000/DAY
ATC code Drug group No.of DDD/1000/day Percentage (%)
A Gastrointestinal and metabolic agents 80.00 13.57
C Cardiovascular agents 283.97 48.16
J Agents for treatment of systemic infections 24.81 4.21
M Musculoskeletal system agents 51.16 8.68
N Nervous system agents 108.21 18.35
R Respiratory system agents 41.46 7.03
Total 591.88 100.00
drug groups according to counties including City of Za-
greb is shown in Table 2.
The City of Zagreb led in drug utilization according to
counties, followed by [ibenik-Knin County and Dubrov-
nik-Neretva County, whereas the lowest drug utilization
was recorded in Zagreb County and Lika-Senj County.
The pattern of particular drug group utilization accord-
ing to counties is more conveniently presented by the
share of particular drug groups expressed as DDD/1000/
day in total outpatient drug utilization in a particular
county (Table 3).
Variation in particular drug group utilization is pre-
sented by RSD (Figure 1).
As illustrated in Figure 1, greatest deviation from the
national average, i.e. highest variation in drug utilization
among particular counties was recorded in group A. Ta-
bles 2 and 3 show that the highest utilization of gastroin-
testinal and metabolic agents was recorded in [ibenik-
-Knin County, where the utilization of this drug group
exceeded the respective national average by 43% (Table
1). It was mainly due to the high utilization of anti-
diabetic drugs (A10) amounting to 57.37 DDD/1000/day,
exceeding the respective drug utilization in any other
county and national mean rate of 36.01 DDD/1000/day
by 38%. The second drug group according to RSD in Cro-
atian counties was group J (Figure 1), with Zadar County
showing highest utilization of this drug group, where it
was by 37% greater than the national mean rate. Besides
Zadar County, a high share of group J in total drug utili-
zation was also recorded in [ibenik-Knin, Istrian, Split-
-Dalmatia and Dubrovnik-Neretva Counties. The high
utilization of group J drugs in these counties was mainly
due to the high utilization of amoxicillin+clavulanate. In
the mentioned counties as well as in the City of Zagreb,
Primorje-Gorski Kotar and Lika-Senj Counties, amo-
xicillin+clavulanate was among the first 20 drugs ac-
cording to utilization, ranking tenth in Zadar County
with 11.48 DDD/1000/day through twentieth with 9.63
DDD/1000/day in the City of Zagreb and with 3.76 DDD/
1000/day in Lika-Senj County. According to RSD, group
N followed with highest utilization in Dubrovnik-Ne-
retva County (Table 2). The highest share of group N
drugs in total drug utilization (Table 3) and second place
according to group N utilization expressed in DDD/1000/
day (Table 2) were recorded in Osijek-Baranya County.
In Dubrovnik-Neretva County, diazepam showed highest
utilization of all prescription drugs, with 38.78 DDD/
1000/day, which was almost twofold diazepam utilization
at the national level. Another three benzodiazepines
were among the 20 leading prescription drugs in Dubrov-
nik-Neretva County, i.e. lorazepam with 16.21 DDD/
1000/day, alprazolam with 11.02 DDD/1000/day, and oxa-
zepam with 9.40 DDD/1000/day. In Osijek-Baranya Co-
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TABLE 2
OUTPATIENT UTILIZATION OF PRESCRIPTION DRUGS EXPRESSED AS DDD/1000/DAY FOR SIX MAIN DRUG GROUPS




A C J M N R
City of Zagreb 115.36 390.81 31.04 65.07 126.43 57.57 786.29
Zagreb County 39.94 147.37 13.54 32.06 56.45 26.00 315.29
Dubrovnik-Neretva County 111.85 278.17 31.55 50.19 148.44 48.68 668.87
Split-Dalmatia County 82.93 228.70 25.76 43.72 101.69 36.94 519.74
[ibenik-Knin County 141.32 294.37 34.07 45.33 124.14 38.19 677.42
Zadar County 110.26 281.26 38.09 56.58 137.50 44.35 668.04
Osijek-Baranya County 64.83 276.86 27.88 60.71 140.97 36.85 608.11
Vukovar-Srijem County 73.51 230.85 19.91 43.54 104.33 30.01 502.15
Virovitica-Podravina County 61.65 255.35 20.35 47.52 108.45 39.34 532.65
Po`ega-Slavonia County 79.45 259.77 29.26 61.32 115.89 40.62 586.31
Brod-Posavina County 44.01 203.38 15.64 35.66 74.08 22.54 395.31
Me|imurje County 60.26 286.01 23.79 44.06 108.47 42.26 564.84
Vara`din County 69.25 358.39 23.29 60.07 98.78 46.72 656.51
Bjelovar-Bilogora County 66.03 285.31 22.33 57.27 97.37 48.72 577.03
Sisak-Moslavina County 76.73 302.65 22.15 44.11 102.80 40.60 589.02
Karlovac County 91.78 320.66 23.01 52.96 86.13 45.26 619.80
Koprivnica-Kri`evci County 69.47 287.06 14.88 55.22 118.59 30.24 575.45
Krapina-Zagorje County 76.57 279.94 20.18 54.86 108.42 41.14 581.10
Primorje-Gorski Kotar County 64.76 273.69 22.45 49.63 106.00 42.98 559.51
Istrian County 83.34 279.18 31.20 44.40 96.80 45.91 580.82
Lika-Senj County 39.49 147.28 12.25 28.70 45.14 20.53 293.38
unty, as many as five group N drugs were among the 20
leading prescription drugs in 2004. These included four
benzodiazepines: diazepam with 21.11 DDD/1000/day,
alprazolam with 20.65 DDD/1000/day, oxazepam with
19.86 DDD/1000/day, and lorazepam with 10.46 DDD/
1000/day. In contrast to all other counties, an analgesic,
metamizole, was among the 20 leading prescription drugs
with 7.19 DDD/1000/day in Osijek-Baranya County.
Group R showed a somewhat lower RSD than group
N, with highest utilization in the City of Zagreb, where
the highest prescribing rate was recorded for loratadine
with 11.02 DDD/1000/day vs. 7.99 DDD/1000/day at the
national level. In the City of Zagreb, the utilization of
fexofenadine was threefold that recorded in Croatia at
primary health care level. Besides the group of anti-
histaminics (R06), the City of Zagreb also had higher uti-
lization of other drug groups for respiratory system at
the secondary level of ATC system than the respective
utilization at the national level.
According to RSD (Figure 1), group R was followed by
group M. The City of Zagreb showed highest utilization
of group M drugs as expressed in DDD/1000/day (Table
2); however, the greatest share of this drug group in total
drug utilization (Table 3) was recorded in Po`ega-Sla-
vonia County, primarily due to the extremely high utili-
zation of diclofenac with 35.38 DDD/1000/day. The utili-
zation of diclofenac was 28.84 DDD/1000/day in the City
of Zagreb and 23.57 DDD/1000/day at the national level.
Diclofenac was by far the most frequently prescribed
group M drug in all Croatian counties. The consumption
of aledronate-sodium was greatest in the City of Zagreb,
where it ranked second according to group M drug utili-
zation. The utilization of aledronate-sodium was 9.16
DDD/1000/day and 5.29 DDD/1000/day in the City of
Zagreb and Croatia, respectively.
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TABLE 3
PERCENTAGE (%) OF SIX MAIN DRUG GROUPS AT PRIMARY LEVEL OF ATC SYSTEM IN TOTAL OUTPATIENT UTILIZATION OF THE




A C J M N R
City of Zagreb 14.67 49.70 3.95 8.28 16.08 7.32 100.00
Zagreb County 12.66 46.74 4.29 10.17 17.90 8.22 100.00
Dubrovnik-Neretva County 16.72 41.59 4.72 7.50 22.19 7.28 100.00
Split-Dalmatia County 15.95 44.00 4.96 8.41 19.57 7.11 100.00
[ibenik-Knin County 20.86 43.45 5.03 6.69 18.33 5.64 100.00
Zadar County 16.62 42.39 5.74 8.53 20.04 6.68 100.00
Osijek-Baranya County 10.66 45.53 4.58 9.98 23.18 6.06 100.00
Vukovar-Srijem County 14.64 45.97 3.96 8.67 20.78 5.98 100.00
Virovitica-Podravina County 11.57 47.94 3.82 8.92 20.36 7.39 100.00
Po`ega-Slavonia County 13.55 44.31 4.99 10.46 19.77 6.93 100.00
Brod-Posavina County 11.13 51.45 3.96 9.02 18.74 5.70 100.00
Me|imurje County 10.67 50.64 4.21 7.80 19.20 7.48 100.00
Vara`din County 10.55 54.59 3.55 9.15 15.05 7.12 100.00
Bjelovar-Bilogora County 11.44 49.44 3.87 9.92 16.87 8.44 100.00
Sisak-Moslavina County 13.03 51.38 3.76 7.49 17.45 6.89 100.00
Karlovac County 14.81 51.74 3.71 8.54 13.90 7.30 100.00
Koprivnica-Kri`evci County 12.07 49.88 2.59 9.60 20.61 5.26 100.00
Krapina-Zagorje County 13.18 48.17 3.47 9.44 18.66 7.08 100.00
Primorje-Gorski Kotar county 11.57 48.92 4.01 8.87 18.95 7.68 100.00
Istrian County 14.35 48.07 5.37 7.64 16.67 7.90 100.00
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Fig 1. Relative standard deviation (RSD) for the main anatomi-
cal groups of ATC system (A, C, J, M, N and R) in Croatian coun-
ties and City of Zagreb in 2004.
Group C with highest utilization in all Croatian coun-
ties showed least between-county variation (RSD, Figure
1) in outpatient utilization. Although an increased con-
sumption of this drug group was observed in the City of
Zagreb (Table 2), Vara`din County accounted for the
greatest share in the utilization of this drug group (Table
3). In the City of Zagreb, the consumption of group C10
drugs (hypolipidemic agents) was almost threefold that
in Vara`din County (60.99 DDD/1000/day versus 23.85
DDD/1000/day). On the other hand, Vara`din County
had a significantly greater utilization of group C09 (142.93
DDD/1000/day), predominated by lisinopril with 66.46
DDD/1000/day. The correlation of outpatient drug utili-
zation in the City of Zagreb and Croatian counties with
the morbidity at primary health care level can be perceiv-
ed by comparing data on drug utilization with Table 4.
Discussion
The absolute and relative indicators of drug utiliza-
tion clearly point to variation in the utilization of partic-
ular drug groups among Croatian counties. According to
total drug utilization in the counties and City of Zagreb,
the latter had highest outpatient drug utilization in
2004. Lowest utilization was recorded in Lika-Senj Co-
unty. These data reflect the fact that 43% of the Croatian
health care resources are located in Zagreb, and some 50
000 people from all parts of Croatia come daily to Zagreb
for various reasons. A great deal of people residing all
over Zagreb County and elsewhere come to Zagreb daily
for work and shopping, probably also taking their pre-
scription drugs in Zagreb pharmacies. The influence of
pharmaceutical industry is rather strong in Zagreb, while
the purchasing power of Zagreb citizens exceeds that in
the rest of Croatia21,22. In contrast to Zagreb, Lika-Senj
County as the least populated Croatian county showed
lowest drug utilization, which could be explained by the
lowest number of medical teams at primary health care
level, lowest rate of visits to primary health care physi-
cians, and highest catchment population referred to sec-
ondary health care level (27% in total, i.e. 20% and 7% re-
ferred to Rijeka University Hospital Center and Zagreb
University Hospital Center, respectively)23. The phar-
macy density is highest in the City of Zagreb, and con-
sumption data are geograficalily caracterized by phar-
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TABLE 4
DISEASES AND STATES* RECORDED IN PRIMARY HEALTH CARE IN THE REPUBLIC OF CROATIA, CITY OF ZAGREB
AND CROATIAN COUNTIES IN 2004, EXPRESSED AS RATE PER 1000 INHABITANTS
County A00-A99 E00-E90 F00-F99 G00-G99 I00-I99 J00-J99 K00-K93 L00-L99 M00-M99 N00-N99
Republic of Croatia 87.18 71.91 81.47 26.40 205.03 553.62 84.75 109.89 182.09 121.47
Zagreb 93.35 53.71 72.83 24.76 171.29 516.37 74.28 101.07 151.53 101.99
Krapina-Zagorje 81.37 58.78 82.85 27.22 200.17 517.94 84.91 114.82 193.26 111.55
Sisak-Moslavina 78.05 72.84 83.60 24.00 225.88 487.50 80.72 94.95 170.80 104.82
Karlovac 95.67 64.63 86.35 23.13 203.25 483.02 98.44 111.98 209.07 114.46
Vara`din 83.27 70.97 81.76 23.71 228.51 549.00 70.28 99.39 185.66 94.18
Koprivnica-Kri`evci 84.23 66.04 102.74 28.61 229.67 466.87 86.49 108.30 227.35 110.88
Bjelovar-Bilogora 95.44 81.61 112.82 30.15 284.07 536.41 90.82 123.91 231.91 144.74
Primorje-Gorski Kotar 125.09 77.60 88.61 31.74 215.27 587.93 102.26 119.32 207.31 127.80
Lika-Senj 43.89 51.18 56.97 18.29 174.32 358.68 64.11 71.54 116.79 60.40
Virovitica-Podravina 88.62 86.52 101.69 33.43 225.57 509.26 94.83 133.99 213.31 124.49
Po`ega-Slavonia 71.08 61.61 75.93 23.26 163.16 403.40 67.87 74.32 167.98 92.72
Brod-Posavina 64.38 73.69 83.86 25.98 214.17 431.79 74.28 97.02 167.41 125.15
Zadar 75.68 91.85 88.01 27.23 250.59 553.96 99.32 115.62 210.92 131.83
Osijek-Baranya 87.18 71.09 91.74 22.70 179.92 560.81 86.29 112.13 172.46 128.94
[ibenik-Knin 50.00 94.24 86.51 32.86 289.25 543.56 93.39 120.04 188.82 120.60
Vukovar-Srijem 61.31 53.48 76.10 17.08 157.28 406.94 59.03 78.36 128.30 83.24
Split-Dalmatia 78.46 76.94 73.99 27.60 202.80 724.18 93.13 131.19 180.17 131.89
Istria 98.47 76.60 69.47 29.29 191.09 621.84 87.35 104.64 203.54 121.51
Dubrovnik-Neretva 37.75 81.74 94.14 38.07 257.48 501.04 102.99 117.21 171.20 147.33
Me|imurje 74.44 64.49 72.59 22.12 163.00 505.78 74.03 83.39 156.90 91.85
City of Zagreb 107.82 73.47 72.92 26.02 194.55 603.78 81.98 115.20 181.42 143.19
*A00-B99 Infectious and parasitic diseases; E00-E90 Endocrine diseases, alimentary disorders and metabolic disorders; F00-F99 Men-
tal disorders and behavioral disturbances; G00-G99 Nervous system diseases; I00-I99 Circulation diseases; J00-J99 Respiratory dis-
eases; K00-K93 Gastrointestinal diseases; L00-L99 Cutaneous and subcutaneous tissue diseases; M00-M99 Musculoskeletal and con-
nective tissue diseases; N00-N99 Genitourinary system diseases
macy location, rather than patients home address, which
also explanes the highest consumption of drugs in the
City of Zagreb.
The real pattern of outpatient drug utilization ac-
cording to counties is better indicated by relative values,
i.e. shares of particular drug group consumption in over-
all drug utilization in particular counties and their varia-
tion. According to these parameters, the share of group
A drug utilization showed greatest between-county dif-
ferences, being highest in [ibenik-Knin County, primar-
ily due to the very high consumption of antidiabetic
agents. Comparison of these figures with morbidity data
indicates the prevalence of endocrine diseases, alimen-
tary disorders and metabolic diseases established at pri-
mary health care to be significantly higher in this county
relative to the rest of Croatia, exceeding the national
mean rate by 24%. Analysis of data on diabetes mellitus
alone yielded a significant difference between [ibenik-
-Knin County and other Croatian regions. In 2004, the
prevalence of diabetes mellitus in [ibenik-Knin County
was 47/1000 vs. 29/1000 in Croatia. At the same time, the
prevalence of diabetes mellitus was lowest in Zagreb
County (19/1000). Accordingly, the high outpatient utili-
zation of antidiabetics in [ibenik-Knin County was con-
sequential to the high prevalence of the disorder in the
area. As this county was exposed to direct war actions
over a long period of time, the impact of prolonged war
stress exposure on the high rate of diabetes in the area
should be considered. However, some other Croatian
counties that had also been exposed to direct war actions
for a long period of time (Vukovar-Srijem and Osijek-
-Baranya Counties) showed no major deviation from the
national mean rate. Considering the multifactorial etiol-
ogy of diabetes mellitus24–27, additional in-depth studies
in the field should be conducted and appropriate public
health actions launched for primary and secondary pre-
vention of the disease in [ibenik-Knin County28.
The share of antibiotic consumption in total drug uti-
lization showed great between-county variation; how-
ever, the utilization of amoxicillin+clavulanate was by
far highest in all counties as well as at the national level.
Comparison with morbidity indicators according to
counties failed to reveal any direct association with the
high consumption of antibiotics in some counties, first of
all Zadar County. Acute respiratory infections are the
most common reason for uneconomical prescribing of
antibiotics29,30. Although outpatient utilization of antibi-
otics requires additional studies and analysis of prescrip-
tion drug utilization in correlation with medical diagno-
sis, the fact that amoxicillin+clavulanate was the most
frequently prescribed antibiotic can be considered nei-
ther rational nor consistent with international research
data that unanimously prefer narrow-spectrum antibioti-
cs31–33. High utilization of broad-spectrum antibiotics is
characteristic of south and east European countries,
whereas north and west European countries give prefer-
ence to narrow-spectrum antibiotics34.
Osijek-Baranya and Dubrovnik-Neretva Counties sho-
wed highest outpatient utilization of psychopharmaceu-
ticals, which could in part be explained by the high preva-
lence of mental disorders (F00-F99) in these counties,
and the highest prevalence of nervous system diseases
(G00-G99), including sleep disorders (G47). Unfortu-
nately, data on isolated G47 diagnosis morbidity were not
available, thus the association of the high consumption of
psychopharmaceuticals, benzodiazepine in particular, in
this county with the morbidity justifying such a high pre-
scribing pattern could only be postulated. The high utili-
zation of benzodiazepines at the national level poses a
question of their rational use because these drugs are
used at a considerably wider scale than the disorders they
are indicated for35–37. The high outpatient utilization of
metamizole in Osijek-Baranya County is not substanti-
ated either by morbidity indicators or by professional and
scientific data38–40.
The highest consumption of group M drugs is in
Po`ega-Slavonia County. The very high utilization of
diclofenac as the leading non-steroidal antirheumatic on
prescription in all Croatian counties is not based on
evidence41–43. The unjustifiably high outpatient utiliza-
tion of this agent should at least in part be ascribed to the
impact of domestic pharmaceutical industry.
The share of cardiovascular drug utilization showed
least between-county variation, being the group of drugs
with highest utilization in all Croatian counties. How-
ever, there was some within-group variation. The City of
Zagreb differed from all other regions according to distri-
bution of particular group C subgroups, yielding a high
consumption of hypolipidemic agents. In Zagreb, the con-
sumption of hypolipidemic agents was twofold (Istrian,
Primorje-Gorski Kotar and Osijek-Baranya Counties) to
threefold (Vara`din, Brod-Posavina and Vukovar-Srijem
Counties) that in the rest of Croatia. The proportion of
cardiovascular drugs in total drug utilization was great-
est in Vara`din County, which was in correlation with the
respective morbidity indicators. The cardiovascular mor-
bidity rate in Zagreb was below the national mean rate.
The cardiovascular mortality rate in has been found to
decline since 2001 in the City of Zagreb while showing a
mild rise in the rest of Croatia44. The increased utiliza-
tion of hypolipidemic agents recorded during the same
period of time in the City of Zagreb45 may have contrib-
uted to such a health pattern, as these agents have been
demonstrated to be efficient in the prevention of cardio-
vascular complications46–48. ACE inhibitors were the most
widely prescribed drugs in all Croatian regions, and pre-
scribing cardiovascular agents does not appear to be ra-
tional in terms of their cost-effectiveness49,50.
The pattern of drug utilization according to counties
would be more comprehensive had all the 14 ATC drug
groups been included in the study. However, as DDD has
not been established for the majority of drugs from the
remaining drug groups, interpretation of their utilization
by use of ATC/DDD methodology would not be reliable.
As the six drug groups included in the study account for
the major part of outpatient drug utilization, we believe
that this survey provides an insight into the main charac-
teristics of drug utilization in all Croatian regions.
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Methodologically, the interpretation of results was
also limited by the fact that data on drug utilization and
morbidity were collected from various sources, thus only
roughly reflecting the association between drug utiliza-
tion and morbidity, i.e. between justifiability and ratio-
nality of drug utilization. The quality of drug prescribing
practice in Croatian counties should be evaluated on pre-
scription samples in correlation with diagnosis associ-
ated with each individual prescription, especially for the
groups of drugs outstanding for a questionable prescrib-
ing pattern such as antibiotics, benzodiazepines, ACE in-
hibitors and metamizole in Osijek-Baranya County. Ap-
propriate public health monitoring of all relevant param-
eters would urgently require complete computerization
of the health care system, in order to minimize data scat-
tering and to reduce the possibility of erroneous inter-
pretation of public health parameters. National guide-
lines on drug prescribing at the primary health care level
should be urgently adopted to make drug utilization in
Croatia more rational.
Conclusion
Outpatient drug utilization shows varying patterns in
different Croatian counties. The high prevalence of dia-
betes mellitus has entailed high utilization of antidia-
betic agents in [ibenik-Knin County. The high preva-
lence of diabetes mellitus in this county poses the need of
additional studies as well as of public health actions and
measures of both primary and secondary prevention.
There is no correlation of the high utilization of broad-
-spectrum antibiotics and morbidity. The high share of
benzodiazepines at the national level points to the need
of proper education of both physicians and population at
large in the rational use of these agents. The utilization
of metamizole is unjustifiably high in Osijek-Baranya
County, and so is the utilization of diclofenac, in Po`ega-
-Slavonia and Osijek-Baranya Counties in particular. The
high utilization of hypolipidemic agents in Zagreb and of
ACE inhibitors at the national level requires additional
cost-effectiveness analysis.
In addition to morbidity, the pattern of drug prescrib-
ing appears to also be considerably influenced by the pre-
scribers’ experience and habits (antibiotics, benzodiaze-
pines), pharmaceutical industry (diclofenac), availability
of latest concepts and drugs, and purchasing power of the
population (hypolipidemics). Accordingly, there is an ob-
vious need of national guidelines on rational drug utiliza-
tion, along with appropriate education of the physicians,
pharmacists and population at large on their implemen-
tation.
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OBILJE@JA IZVANBOLNI^KE POTRO[NJE [EST GLAVNIH ATK SKUPINA LIJEKOVA U
REPUBLICI HRVATSKOJ, GRADU ZAGREBU I @UPANIJAMA REPUBLIKE HRVATSKE U 2004.
GODINI
S A @ E T A K
Cilj ovoga rada je utvrditi potro{nju lijekova u regijama Republike Hrvatske te istra`iti uzroke eventualnih razlika u
potro{nji me|u regijama. Zavod za javno zdravstvo Grada Zagreba, u suradnji sa Agencijom za lijekove i medicinske
proizvode, prikupljao je i analizirao podatke o izvanbolni~koj potro{nji lijekova iz {est glavnih Anatomsko-Terapijsko-
-Kemijskih (ATK) skupina. Podaci o broju i veli~ini pakovanja te financijskim iznosima prema veleprodajnim cijenama
dobiveni su iz svih ljekarni u Hrvatskoj. Na temelju dobivenih podataka, za sve lijekove je izra~unat broj definiranih
dnevnih doza (DDD) i broj DDD na 1000 stanovnika na dan (DDD/1000/dan). Razlike u potro{nji lijekova me|u `upa-
nijama, izra~unate su za {est promatranih ATK skupina pomo}u relativne standardne devijacije (RSD). Utvr|eno je da
postoje razlike u izvanbolni~koj potro{nji lijekova me|u regijama Hrvatske. Iz prikazanih rezultata, name}e se potreba
dono{enja nacionalnih smjernica za racionalnu primjenu lijekova te edukacija lije~nika, ljekarnika i {ire populacije o
potrebi primjene istih.
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